Actinium Pharmaceuticals (Delaware) (ATNM) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 11, 2026.
Summary
Actinium Pharmaceuticals (Delaware) (ATNM) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, losing 26.2% versus a loss of 40.8%. Actinium Pharmaceuticals (Delaware) is the larger company by market cap ($34.6 million vs $31.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATNM | MIRA |
|---|---|---|
| Share price | $1.10 | $0.7455 |
| Market cap | $34.59M | $31.33M |
| 1-day change | +1.85% | +6.05% |
| YTD return | -19.12% | -50.63% |
| 1-year return | -26.17% | -40.83% |
| 5-year return | -86.32% | — |
| P/E ratio (TTM) | 3.06 | — |
| EPS (TTM) | $0.36 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.74 | $2.45 |
| 52-week low | $0.735 | $0.60 |
| Distance from 52-week high | -36.78% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +227.27% | +369.48% |
| Average volume | 140.25K | 585.04K |
| Shares outstanding | 31.44M | 42.02M |
| Employees | 27 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATNM has outperformed MIRA by 14.7 percentage points over the past year.
About Actinium Pharmaceuticals (Delaware)
ATNM stock →Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 27 employees
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
ATNM vs MIRA FAQ
Which is bigger, Actinium Pharmaceuticals (Delaware) or MIRA Pharmaceuticals?
Actinium Pharmaceuticals (Delaware) (ATNM) is larger, with a market capitalization of $34.59M compared with $31.33M for MIRA Pharmaceuticals (MIRA).
Which stock has performed better over the past year, ATNM or MIRA?
ATNM returned -26.17% over the past 12 months, compared with -40.83% for MIRA (price return, excluding dividends). Past performance does not predict future results.
Are Actinium Pharmaceuticals (Delaware) and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.